RareCyte
Company

Last deal

$20M

Amount

Venture - Series Unknown

Stage

27.06.2024

Date

3

all rounds

$96M

Total amount

date founded

Financing round

General

About Company
RareCyte is a life science research and diagnostic development company that isolates rare cells in the blood.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

founders

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's AccuCyte system is an open platform for discovering and isolating circulating tumor cells and endothelial cells from whole blood. RareCyte's cell discovery kit detects circulating tumor cells and provides a sensitive, accurate, and reproducible workflow for clinical research. The company offers Spatial Biology and Liquid Biopsy solutions, including highly multiplexed fluorescent imaging systems, reagents, and contract services, to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
ApoCell

ApoCell

ApoCell is a molecular biomarker development, services, and diagnostics company based in Houston.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Houston, TX, USA

total rounds

1
Biolidics

Biolidics

Biolidics is a medical technology company that develops cell enrichment systems to improve cancer diagnostics and patient care.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Singapore

total rounds

2

total raised

$11.76M
Quanterix

Quanterix

Quanterix developed Simoa, a platform for single-molecule analysis in diagnostics, drug development, and research.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Life Science

Location

Billerica, MA, USA

total rounds

12

total raised

$533.3M
BioElectron Technology Corporation

BioElectron Technology Corporation

BioElectron is a company that develops redox drugs to treat genetic disorders and neurodegenerative diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Mountain View, CA, USA

total rounds

3

total raised

$47.67M

Financials

Funding Rounds
6
3

Number of Funding Rounds

$96M

Money Raised

Their latest funding was raised on 27.06.2024. Their latest investor 5AM Ventures. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
F-Prime Capital

F-Prime Capital

F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Cambridge, MA, USA

count Of Investments

356

count Of Exists

44
Arboretum Ventures

Arboretum Ventures

Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Venture Capital, Health Care, Financial Services

Location

Ann Arbor, MI, USA

total rounds

1

total raised

$5M

count Of Investments

89

count Of Exists

20
Gastro-Intestinal Research Foundation

Gastro-Intestinal Research Foundation

For more than 50 years, we have devoted ourselves to making life better for patients and families living with digestive diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Non-Profit

Location

Chicago, IL, USA

count Of Investments

5
Arboretum Ventures

Arboretum Ventures

Arboretum Ventures is a Michigan-based venture capital firm investing in medical technology and healthcare companies.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Venture Capital, Health Care, Financial Services

Location

Ann Arbor, MI, USA

total rounds

1

total raised

$5M

count Of Investments

89

count Of Exists

20
Co-Investors
Investors
12
3

Number of lead investors

12

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
Yes
Venture - Series Unknown
No
Series G, Venture - Series Unknown
5AM Ventures

5AM Ventures

5AM Ventures is a venture capital firm that invests in early-stage companies in the life sciences industry.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Menlo Park, CA, USA

count Of Investments

154

count Of Exists

19
F-Prime Capital

F-Prime Capital

F-Prime Capital is a venture capital firm that invests in technology, healthcare and life sciences sectors in the United States and Europe.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Health Care

Location

Cambridge, MA, USA

count Of Investments

356

count Of Exists

44
Agilent Technologies

Agilent Technologies

Agilent provides laboratory solutions to meet the needs of analytical scientists and clinical researchers worldwide.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Biotechnology, Clinical Trials

Location

Santa Clara, CA, USA

total rounds

1

total raised

$500M

count Of Investments

31

count Of Exists

7

People

Founders
1

Ron Seubert

Ron Seubert is the founder, President, and CEO of RareCyte. Previously Ron was co-founder of both Applied Precision LLC and Applied Precision Inc. (API). Over a period of 20 years as President and CEO, Ron led these companies through consistent and rapid growth by developing innovative products in both the life sciences and semi-conductor industries. Most notably, API developed the DeltaVision microscopy line of products that led the way in live cell and high resolution microscopy as well as an OEM business that built technologies for companies like Becton Dickinson (NYSE: BDX). In 2011, API was sold to GE Healthcare and RareCyte was spun-out with an equity investment from Telegraph Hill Partners and management.

current job

Applied Precision, Inc.
Applied Precision, Inc.

count Of Investments

4

Ron Seubert

Employee Profiles
14

Sandra Tarasow

Senior executive assistant

Tony Dedeo

Vice president of operations and quality | start up - iso13485:2016 compliance â cost reduction - lean

Melinda Duplessis

Applications scientist

Joseph Victor

President & CEO

Guy Page

Interim marketing director

Ned Shafer

Senior electrical engineer

Russell Horn

It systems engineer

Eric Kaldjian

Chief medical officer

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month